SHL Medical is excited to announce our participation in the 2023 PFSS Tokyo organized by PDA Japan Chapter on September 12-13 at Sola City Conference Center
Menu
SHL Medical is pleased to announce the appointment of Markus Puusepp as Chief Growth Officer (CGO). As CGO, Puusepp will be responsible for accelerating the company’s growth with a focus on innovation and customer experience.
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical’s response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcoming Swiss manufacturing site in Zug.
In the June issue of ONdrug Delivery magazine, SHL Medical’s Chelsea Williams, Nils Weber, and Gene Rhode Fuensalida Pantig, discuss the potential of collaborative digital health innovation programs toward developing high-impact adherence solutions that harness the power of data.
SHL will provide its device development expertise, assembly guidance, and production competencies to support the clinical and potential commercial supply of the sonelokimab project.
SHL Medical announced today the release of its Sustainability Report for 2022. The report provides a comprehensive overview of the company’s efforts to promote sustainability and outlines its commitment to a sustainable future.
SHL Medical is pleased to announce the appointment of Gwenaël Rouy-Poirier as Chief Financial Officer (CFO) of SHL and a member of the Executive Management Team as of May 2, 2023.
SHL Medical achieves ISO 14001 Environmental Management Systems certification and ISO 45001 Occupational Health and Safety Management Systems certification.
SHL Medical is pleased to announce our participation in CPHI Japan 2023 for the first time.
